|
Listed below are a few of the protocols
available for genitourinary cancers.
- A phase II randomized trial for patients
with muscle-invading bladder cancer
evaluating transurethral surgery
and BID irradiation plus either paclitaxel
and cisplatin or 5-fluorouracil and
cisplatin followed by selective bladder
preservation and gemcitabine/paclitaxel/
cisplatin adjuvant chemotherapy
- Atrasentan and zometa for men with
androgen independent prostate cancer
metastatic to bone: A randomized
pilot study.
- Zoledronic acid to prevent bone loss
during androgen deprivation therapy
for prostate cancer
- A phase II study of single-agent
SU011248 in the second-line treatment
of patients with metastatic renal
cell carcinoma
Read
more about clinical research
in genitourinary cancers.
|
